-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nervous system diseases are the main cause of disease, and Parkinson's disease (PD) is the fastest growing
PD is a neurodegenerative disease associated with advancing age
Currently, few studies have explored the long-term disease costs of PD, and even fewer have combined clinical and administrative databases
Therefore, Ming Li Emily Soha et al.
management diagnostics
Core objectives:
1,162 patients met study inclusion criteria, and 1,157 matched controls were identified
Compared with the control group, patients' total average annual medical expenses (calculated by 2017 expenses) increased significantly in the years 1-9 after diagnosis
Increased costs were observed 2 years before diagnosis ($2322 vs.
The significance of this study lies in its findings: PD leads to higher health care utilization and costs
PD leads to higher healthcare utilization and costs
Longitudinal Healthcare Utilization and Costs in Parkinson's Disease: Pre-Diagnosis to 9 Years After.
Leave a Comment here
